Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages

British Journal of Dermatology

Volumn 149, Issue 5, 2003, Pages 1029-1034

  Arkwright, P D ^a   David, T J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Age; Atopic dermatitis; Children; Mycobacterium vaccae; Randomized controlled trial

Indexed keywords

PROBIOTIC AGENT;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM VACCAE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANTI-BACTERIAL AGENTS; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; META-ANALYSIS; MYCOBACTERIUM; TREATMENT OUTCOME; VACCINES, INACTIVATED;

EID: 0346751969     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2003.05557.x     Document Type: Article

References (16)

1. Leung DY. Atopic dermatitis and the immune system: the role of superantigens and bacteria. J Am Acad Dermatol 2001; 45: S13-16.
2. Kalliomaki M, Salminen S, Arvilommi H et al. Probiotics in primary prevention of atopic disease; a randomised placebo-controlled trial. Lancet 2001; 357: 1076-9.
3. von Mutius E, Pearce N, Beasley R et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis and eczema. Thorax 2000; 55: 449-53.
4. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1997; 275: 77-9.
5. Hopkin JM, Shaldon S, Ferry B et al. Mycobacterial immunisation in grass pollen asthma and rhinitis. Thorax 1998; 53 (Suppl. 4): S63.
6. Shirtcliffe PM, Easthope SE, Cheng S et al. The effect of delipidated deglycolipidated (DDMV) and heat-killed Mycobacterium vaccae in asthma. Am J Respir Crit Care Med 2001; 163: 1410-14.
7. Camporota L, Corkhill A, Long H et al. The effects of Mycobacterium vaccae on allergeninduced airway responses in atopic asthma. Eur Respir J 2003; 21: 287-93.
8. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin lmmunol 2001; 107: 531-4.
9. Berth-Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol 1996; 135: 25-30.
10. David TJ, Wells FE, Sharpe TC, Gibbs AC. Low serum zinc in children with atopic dermatitis. Br J Dermatol 1984; 111: 597-601.
11. Miller FJW, Seal RME, Taylor MD. Tuberculosis in Children. Boston: Little, Brown and Co., 1963.
12. Smith J, Jacobs RF, Wilson CB. Immunobiology of childhood tuberculosis: a window on the ontogeny of cellular immunity. J Pediatr 1997; 131: 16-26.
13. Williams HC, Wuthrich B. The natural history of atopic dermatitis. In: Atopic Dermatitis. The Epidemiology, Causes and Prevention of Atopic Dermatitis (Williams HC, ed.). Cambridge: Cambridge University Press, 2000; 46-7.
14. Curotto de Lafaille MA, Lafaille JJ. CD4(+) regulatory T cells in autoimmunity and allergy. Curr Opin Immunol 2002; 14: 771-8.
15. Arkwright PD, Chase JM, Babbage S et al. Atopic dermatitis is associated with a low-producer transforming growth factor P1 cytokine genotype. J Allergy Clin Immunol 2001; 108: 281-4.
16. Zuany-Amorim C, Sawicka E, Manlius C et al. Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat Med 2002; 8: 625-9.